flaticon1486395519-svgnoun_815769_ffffffblood-donationbloodstanding-human-body-silhouettebreast-implantchat (1)Shapenoun_1218658noun_1151816clockGroupcontractcrossdonationflaticon1483626445-svgeyefoot-side-view-outlinegroup (2)stopinfokidneyShapelungsmail (1)son (2)motherplaceholder (2)plastic-surgeryribbonsmall-calendarspinal-columnstomachsuccessinjection

RCT is conducting a new clinical trial on participants with asthma; this exciting novel treatment uses an anti-inflammatory agent that targets an important component of the immune response system.

People eligible for this study include those with mild allergic asthma between the ages of 18 and 60 and are either a non-smoker or an ex-smoker.

We are just entering our recruitment phase so if you would like more information about this clinical trial or to register your interest, please call us on 0800 023 4824 or 020 7034 3341, or email – recruitment@heartlungcentre.com or register at www.heartlungcentre.com.



Enquire Today

Contact us to discuss how RCT can assist your organisation with the design, implementation and management of clinical trials

Contact Us